Transcriptional Regulation of Type I Receptor Tyrosine Kinases in the Mammary Gland

  • Nicholas P. Bates
  • Helen C. HurstEmail author


The transcriptional regulation of the human EGFR3 and ERBB2 genes has been extensively studied, particularly in the context of their overexpression in breast cancer. Here we summarize published work detailing the transcription factors which interact with the promoters of these and the rat ERBB2 homologue, neu, genes and discuss their possible relevance to gene activation in cancer. In addition we review the biologically significant molecules which modulate expression of these genes and discuss the nuclear factors involved in mediating these responses. We also describe novel therapies which may result from these studies and highlight directions for future research into the control of expression of the EGFR and ERBB2 genes in the normal mammary gland and in breast cancer.

EGFR ErbB2 Neu ErbB3 transcription 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Sibilia and E. F. Wagner (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234–238.Google Scholar
  2. 2.
    K.-F. Lee, H. Simon, H. Chen, B. Bates, M. Hung, and C. Hauser (1995). Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378:394–398.Google Scholar
  3. 3.
    M. Gassmann, F. Casagranda, D. Orioli, H. Simon, C. Lai, R. Klein, and G. Lemke (1995). Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378:390–394.Google Scholar
  4. 4.
    G. T. Merlino (1990). Epidermal growth factor receptor regulation and function. Semin. Cancer Biol. 1:277–284.Google Scholar
  5. 5.
    S. A. Chrysogelos and R. B. Dickson (1994). EGF receptor expression, regulation, and function in breast-cancer. Breast. Cancer Res. Treat. 29:29–40.Google Scholar
  6. 6.
    N. E. Davidson, E. P. Gelmann, M. E. Lippman, and R. B. Dickson (1987). Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol. 1:216–223.Google Scholar
  7. 7.
    J. Haley, N. Whittle, P. Bennet, D. Kinchington, A. Ullrich, and M. Waterfield (1987). The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res. 1:375–396.Google Scholar
  8. 8.
    S. Ishii, Y. H. Xu, R. H. Stratton, B. A. Roe, G. T. Merlino, and I. Pastan (1985). Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 82:4920–4924.Google Scholar
  9. 9.
    R. I. Yarden, A. H. Lauber, D. Elashry, and S. A. Chrysogelos (1996). Bimodal regulation of epidermal growth-factor receptor by estrogen in breast-cancer cells. Endocrinology 137:2739–2747.Google Scholar
  10. 10.
    A. C. Johnson (1996). Activation of epidermal growth-factor receptor gene-transcription by phorbol 12-myristate 13-acetate is mediated by activator protein-2. J. Biol. Chem. 271:3033–3038.Google Scholar
  11. 11.
    L. G. Hudson, K. L. Thompson, J. Xu, and G. N. Gill (1990). Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 87:7536–7540.Google Scholar
  12. 12.
    J. Xu, K. L. Thompson, L. B. Shephard, L. G. Hudson, and G. N. GIll (1993). T(3) receptor suppression of spl-dependent transcription from the epidermal growth-factor receptor promoter via overlapping DNA-binding sites J. Biol. Chem. 268:16065–16073.Google Scholar
  13. 13.
    J. A. Fernandez Pol, P. D. Hamilton, and D. J. Klos (1989). Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor beta 1, and triiodothyronine in MDA-468 cells. J. Biol. Chem. 264:4151–4156.Google Scholar
  14. 14.
    D. Gross and W. Garrard (1988). Nuclease hypersensitive sites in chromatin. Ann. Rev. Biochem. 57:159–197.Google Scholar
  15. 15.
    S. A. Chrysogelos. (1993). Chromatin structure of the EGFR gene suggests a role for intron-1 sequences in its regulation in breast-cancer cells. Nucleic Acids Res. 21:5736–5741.Google Scholar
  16. 16.
    J. D. Haley and M. D. Waterfield (1991). Contributory effects of de Novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis. J. Biol. Chem. 266:1746–1753.Google Scholar
  17. 17.
    T. Maekawa, F. Imamoto, G. T. Merlino, I. Pastan, and S. Ishii (1989). Cooperative function of two separate enhancers of the human epidermal growth factor receptor proto-oncogene. J. Biol. Chem. 264:5488–5494.Google Scholar
  18. 18.
    D. J. Slamon, W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press (1989). Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.Google Scholar
  19. 19.
    C. Wright, S. Nicholson, B. Angus, J. Sainsbury, J. Farndon, J. Cairns, A. Harris, and C. Horne (1992). Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Brit. J. Cancer. 65:118–121.Google Scholar
  20. 20.
    H. Muss, A. Thor, D. Berry, T. Kute, E. Liu, F. Koerner, M. Cirrincione, D. Budman, W. Wood, M. Barcos, and I. Henderson (1994). c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. New Engl. J. Med. 330:1260–1266.Google Scholar
  21. 21.
    M. Kraus, N. Popescu, S. Amsbaugh, and C. King (1987). Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO Journal. 6:605–610.Google Scholar
  22. 22.
    S. Miller, T. Suen, T. Sexton, and M. Hung. (1994). Mechanisms of deregulated her2/neu expression in breast-cancer cell-lines. Intl. J. Oncology 4:599–608.Google Scholar
  23. 23.
    D. P. Hollywood and H. C. Hurst (1993). A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumor lines. EMBO J. 12:2369–2375.Google Scholar
  24. 24.
    F. Pasleau, M. Grooteclaes, and R. Golwinkler (1993). Expression of the c-erbB-2 gene in the BT474 human mammary tumor cell-line—measurement of c-erbB-2 messenger-RNA half-life. Oncogene 8:849–854.Google Scholar
  25. 25.
    S. Ishii, F. Imamoto, Y. Yamanishi, K. Toyoshima, and T. Yamamoto (1987). Characterization of the promoter region of the human c-erbB-2 protooncogene. Proc. Natl. Acad. Sci. U.S.A. 84:4374–4378.Google Scholar
  26. 26.
    M. Tal, C. King, M. Kraus, A. Ullrich, J. Schlessinger, and D. Givol (1987). Human her2 (neu) promoter—evidence for multiple mechanisms for transcriptional initiation. Mol. Cell. Biol. 7:2597–2601.Google Scholar
  27. 27.
    G. Mizuguchi, C. Kaneiishii, T. Sawazaki, M. Horikoshi, R. Roeder, T. Yamamoto, and S. Ishii (1994). Independent control of transcription initiations from 2 sites by an initiator-like element and tata box in the human c-erbB-2 promoter. FEBS Letters. 348:80–88.Google Scholar
  28. 28.
    T. Suen and M. Hung (1990). Multiple cis-acting and trans-acting elements involved in regulation of the neu gene. Mol. Cell. Biol. 10:6306–6315.Google Scholar
  29. 29.
    M. White and M. Hung (1992). Cloning and characterization of the mouse neu promoter. Oncogene 7:677–683.Google Scholar
  30. 30.
    L. Hudson, A. Ertl, and G. GIll (1990). Structure and inducible regulation of the human c-erbB-2/neu promoter. J. Biol. Chem. 265:4389–4393.Google Scholar
  31. 31.
    A. Ertl and G. Gill (1993). Structural features of the 5′ region of the human erbB-2 gene. Gene. 136:361–364.Google Scholar
  32. 32.
    G. Scott, J. Daniel, X. Xiong, R. Maki, D. Kabat, and C. Benz (1994). Binding of an ETS-related Protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J. Biol. Chem. 269:19848–19858.Google Scholar
  33. 33.
    J. M. Bosher, T. Williams, and H. C. Hurst (1995). The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. U.S.A. 92:744–747.Google Scholar
  34. 34.
    J. Bosher, N. F. Totty, J. J. Hsuan, T. Williams, and H. C. Hurst (1996). A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13:1701–1707.Google Scholar
  35. 35.
    F. Sarkar, M. Smith, T. Hoover, G. Princler, J. Crissman, D. Visscher, D. Longo, H. Kung, and Raziuddin (1994). c-erbB-2 promoter-specific DNA-binding protein isolated from human breast-cancer tissues displays mitogenic activity. J. Biol. Chem. 269:12285–12289.Google Scholar
  36. 36.
    Y. Chen and G. Gill (1994). Positive and negative regulatory elements in the human erbB-2 promoter. Oncogene 9:2269–2276.Google Scholar
  37. 37.
    Y. Chen and G. Gill (1996). A heterodimeric nuclear-protein complex binds 2 palindromic sequences in the proximal enhancer of the human erbB-2 gene. J. Biol. Chem. 271:5183–5188.Google Scholar
  38. 38.
    M. Guerin, Z.-M. Sheng, N. Andrieu, and G. Riou (1990). Strong association between c-myb and estrogen-receptor expression in human breast cancer. Oncogene 5:131–135.Google Scholar
  39. 39.
    G. Mizuguchi, C. Kaneiishii, T. Takahashi, T. Yasukawa, T. Nagase, M. Horikoshi, T. Yamamoto, and S. Ishii (1995). c-myb repression of c-erbB-2 transcription by direct binding to the c-erbB-2 promoter. J. Biol. Chem. 270:9384–9389.Google Scholar
  40. 40.
    M. Grooteclaes, F. Pasleau, H. Dijkmans, P. Berzi, A. Albert, and R. Winklergol (1994). The 6-kilobase c-erbB-2 promoter contains positive and negative regulatory elements functional in human mammary cell-lines. Cancer Res. 54:4193–4199.Google Scholar
  41. 41.
    D. Taverna, S. Antoniotti, P. Maggiora, C. Dati, M. DeBortoli, and N. Hynes (1994). ErbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. Int. J. Cancer. 56:522–528.Google Scholar
  42. 42.
    C. Dati, S. Antoniotti, D. Taverna, I. Perroteau, and M. De Bortoli (1990). Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5:1001–1006.Google Scholar
  43. 43.
    K. S. Russell and M.-C. Hung (1992). Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Cancer Res. 52:6624–6629.Google Scholar
  44. 44.
    S. Antoniotti, P. Maggiora, C. Dati, and M. DeBortoli (1992). Tamoxifen up-regulates c-erbB-2 expression in estrogen-responsive breast-cancer cells in vitro. Eur. J. Cancer. 28:318–321.Google Scholar
  45. 45.
    C. Shih, L. C. Padhy, M. Murray, and R. A. Weinberg (1981). Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261–264.Google Scholar
  46. 46.
    D. Yan and M. Hung (1991). Identification and characterization of a novel enhancer for the rat neu promoter. Mol. Cell. Biol. 11:1875–1882.Google Scholar
  47. 47.
    D. Yan and M. Hung (1993). Differential activity of the rvf enhancer element in the decreased expression of the neu oncogene in nr-6 cells versus parental swiss webster 3T3 cells. Mol. Carcin. 7:44–49.Google Scholar
  48. 48.
    X. Zhao and M. Hung (1992). Negative autoregulation of the neu gene is mediated by a novel enhancer. Mol. Cell. Biol. 12:2739–2748.Google Scholar
  49. 49.
    C. Galang, J. Garciaramirez, P. Solski, J. Westwick, C. Der, N. Neznanov, R. Oshima, and C. Hauser (1996). Oncogenic neu/erbb-2 increases ets, AP-1, and nf-kappa-b-dependent gene-expression, and inhibiting ets activation blocks neu-mediated cellular-transformation. J. Biol. Chem. 271:7992–7998.Google Scholar
  50. 50.
    D. Yu, K. Scorsone, and M. Hung (1991). Adenovirus type-5 ela gene-products act as transformation suppressors of the neu oncogene. Mol. Cell. Biol. 11:1745–1750.Google Scholar
  51. 51.
    D. Yan, L. Chang, and M. Hung (1991). Repressed expression of the her-2/c-erbB-2 protooncogene by the adenovirus ela gene products. Oncogene 6:343–345.Google Scholar
  52. 52.
    D. Yu, T. Suen, D. Yan, L. Chang, and M. Hung (1990). Transcriptional repression of the neu protooncogene by the adenovirus-5 ela gene-products. Proc. Natl. Acad. Sci. U.S.A. 87:4499–4503.Google Scholar
  53. 53.
    A. Matin and M. Hung (1993). Negative regulation of the neu promoter by the SV40 large T-antigen. Cell Growth Differ. 4:1051–1056.Google Scholar
  54. 54.
    T. Suen and M. Hung. (1991). C-myc reverses neu-induced transformed morphology by transcriptional repression. Mol. Cell. Biol. 11:354–362.Google Scholar
  55. 55.
    D. Yu, A. Matin, and M. Hung (1992). The retinoblastoma gene-product suppresses neu oncogene-induced transformation via transcriptional repression of neu. J. Biol. Chem. 267:10203–10206.Google Scholar
  56. 56.
    A. Matin and M. Hung. (1994). The retinoblastoma gene-product, Rb, represses neu expression through 2 regions within the neu regulatory sequence. Oncogene 9:1333–1339.Google Scholar
  57. 57.
    A. Matin, Y. Xie, M. Kao, and M. Hung (1995). Rodent p53 suppresses the transforming activity of the activated neu oncogene by modulating the basal promoter activity of neu. Int. J. Oncol. 6:1087–1092.Google Scholar
  58. 58.
    S. Miller and M. Hung (1995). Regulation of her2/neu gene-expression (review). Oncology Reports 2:497–503.Google Scholar
  59. 59.
    S. Noonberg, G. Scott, C. Hunt, M. Hogan, and C. Benz (1994). Inhibition of transcription factor-binding to the her2 promoter by triplex-forming oligodeoxyribonucleotides. Gene. 149:123–126.Google Scholar
  60. 60.
    J. Gee, R. Yen, M. Hung, and M. Hogan (1994). Triplex formation at the rat neu oncogene promoter. Gene. 149:109–114.Google Scholar
  61. 61.
    D. P. Hollywood and H. C. Hurst (1995). Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma. Br. J. Cancer 71:753–757.Google Scholar
  62. 62.
    J. D. Harris, A. A. Gutierrez, H. C. Hurst, K. Sikora, and N. R. Lemoine (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy. 1:1–6.Google Scholar
  63. 63.
    A. Skinner and H. C. Hurst (1993). Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. Oncogene 8:3393–3401.Google Scholar
  64. 64.
    K. Shiga, C. Shiga, H. Sasano, S. Miyazaki, T. Yamamoto, M. Yamamoto, N. Hayashi, T. Nishihira, and S. Mori (1993). Expression of c-erbB-2 in human esophageal-carcinoma cells—overexpression correlated with gene amplification or with gata-3 transcription factor expression. Anticancer Res. 13:1293–1301.Google Scholar
  65. 65.
    A. C. Johnson, Y. Jinno, and G. T. Merlino (1988). Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nuclease. Mol. Cell. Biol. 8:4174–4184.Google Scholar
  66. 66.
    A. C. Johnson, S. Ishii, Y. Jinno, I. Pastan, and G. T. Merlino (1988). Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J. Biol. Chem. 263:5693–5699.Google Scholar
  67. 67.
    R. Kageyama, G. T. Merlino, and I. Pastan (1988). Epidermal growth factor (EGF) receptor gene transcription. Requirement for Spl and an EGF receptor-specific factor. J. Biol. Chem. 263:6329–6336.Google Scholar
  68. 68.
    L. L. Chen, M. L. Clawson, S. Bilgrami, and G. Carmichael (1993). A sequence-specific single-stranded DNA-binding protein that is responsive to epidermal growth-factor recognizes an sl nuclease-sensitive region in the epidermal growth-factor receptor promoter. Cell Growth Differ. 4:975–983.Google Scholar
  69. 69.
    R. Kageyama, G. T. Merlino, and I. Pastan (1988). A transcription factor active on the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 85:5016–5020.Google Scholar
  70. 70.
    R. Kageyama, G. T. Merlino, and I. Pastan (1989). Nuclear factor ETF specifically stimulates transcription from promoters without a TATA box. J. Biol. Chem. 264:15508–15514.Google Scholar
  71. 71.
    R. Kageyama and I. Pastan (1989). Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell. 59:815–825.Google Scholar
  72. 72.
    X. Y. Hou, A. C. Johnson, and M. R. Rosner (1994). Identification of an epidermal growth-factor receptor transcriptional repressor. J. Biol. Chem. 269:4307–4312.Google Scholar
  73. 73.
    X. Y. Hou, A. C. Johnson, and M. R. R. Rosner (1994). Induction of epidermal growth-factor receptor gene-transcription by transforming growth-factor-beta-1-association with loss of protein-binding to a negative regulatory element. Cell Growth. Differ. 5:801–809.Google Scholar
  74. 74.
    L. G. Hudson, J. B. Santon, and G. N. Gill (1989). Regulation of epidermal growth factor receptor gene expression. Mol. Endocrinol. 3:400–408.Google Scholar
  75. 75.
    J. D. Bjorge, A. J. Paterson, and J. E. Kudlow (1989). Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line. J. Biol. Chem. 264:4021–4027.Google Scholar
  76. 76.
    L. C. Murphy, L. J. Murphy, and R. P. Shiu (1988). Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells. Biochem. Biophys. Res. Commun. 150:192–196.Google Scholar
  77. 77.
    L. G. Hudson, J. B. Santon, C. K. Glass, and G. N. Gill (1990). Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell. 62:1165–1175.Google Scholar
  78. 78.
    Z. S. Zheng, R. Polakowska, A. Johnson, and L. A. Goldsmith (1992). Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth. Differ. 3:225–232.Google Scholar
  79. 79.
    S. P. Deb, R. M. Munoz, D. R. Brown, M. A. Subler, and S. Deb (1994). Wild-type human p53 activates the human epidermal growth-factor receptor promoter. Oncogene 9:1341–1349.Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  1. 1.ICRF Oncology UnitRoyal Postgraduate Medical SchoolLondonUnited Kingdom

Personalised recommendations